GV Meditech has always been committed to improve access to quality health care in an affordable way. Keeping up with this commitment we have partnered with Bosch India Limited and Intellecap (Intellectual Capital Advisory Services Limited) for the Rockefeller Foundation UCCR TA Project on diagnostic solutions for Malaria to help establish proof of concept for diagnostic solution for a vector borne disease such as Malaria. The objective is to develop a solution that is accessible, accurate and affordable.
The envisaged new diagnostic solution is based on patented technology and has potential to detect malaria in early stages with accuracy matching to the existing gold standard i.e. PCR. This technology is being tested in many parts of the world.
G.V. Meditech has organized more that 150 health camps inorder to create awareness and educate people.
The first pahase of pilot aimed to establish efficacy of the technology in the Indian conditions. In the pilot we did not made any kind of medical intervention but only added a test in the regular malaria diagnosis procedure. The cost of conducting this additional test was borne by us and hence did not caused any financial burden on the patient. The whole process was governed by an ethical committee which ensured willingness of the patient has been taken before conducting the test.
The duration of the first phase of the pilot, from January 2014 to May 2014, has been completed successfully in Varanasi, Mirzapur, Sonbhadra, Gorakhpur and Kushinagar districts.